Standout Papers

Further studies on the mechanism of antipsychotic action: Potentiation by ?-methyltyros... 1970 2026 1988 2007 62
  1. Further studies on the mechanism of antipsychotic action: Potentiation by ?-methyltyrosine of thioridazine effects in chronic schizophrenics (1973)
    Arvid Carlsson, B. E. Roos et al. Journal of Neural Transmission
  2. Potentiation of phenothiazines by?-methyltyrosine in treatment of chronic schizophrenia (1972)
    Arvid Carlsson, Torgny Persson et al. Journal of Neural Transmission
  3. ORALL‐DOPA TREATMENT OF PARKINSONISM (1970)
    N.‐E. Andén, Arvid Carlsson et al. Acta Medica Scandinavica

Citation Impact

Citing Papers

Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease
1981
Genetic Dissection of the Amyloid Precursor Protein in Developmental Function and Amyloid Pathogenesis
2010 StandoutNobel
Inflammatory processes in Alzheimer's disease
2007
Inducible Nitric-oxide Synthase and Nitric Oxide Production in Human Fetal Astrocytes and Microglia
1997 StandoutNobel
Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.
1994
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice
1995 StandoutNatureNobel
A Hundred Years of Alzheimer's Disease Research
2006
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
2000 Standout
Mice Deficient in Golf Are Anosmic
1998 StandoutNobel
C. elegans Locomotory Rate Is Modulated by the Environment through a Dopaminergic Pathway and by Experience through a Serotonergic Pathway
2000 StandoutNobel
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
2012 StandoutNature
An application of prefrontal cortex function theory to cognitive aging.
1996 Standout
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Ventilatory and central neurochemical reorganisation of O2 chemoreflex after carotid sinus nerve transection in rat
2000
Increased monoamine oxidase b activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography
1994
Time- and dose-related changes in the white matter of the rat brain after single doses of X rays
1988
Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication
1995
Synaptic connections between medullary respiratory neurons and considerations on the genesis of respiratory rhythm
1990
Enzymatic functionalization of carbon–hydrogen bonds
2010 StandoutNobel
Postmortem Stability of Monoamines, Their Metabolites, and Receptor Binding in Rat Brain Regibns
1994
Why sex matters for neuroscience
2006 Standout
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
2003
Snoring, Hypertension, and the Sleep Apnea Syndrome
1993
The molecular neurobiology of depression
2008 StandoutNature
Basal Ganglia Dopamine Receptor Autoradiography and Age‐related Movement Disordersa
1988
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
2002
Brain angiotensin receptor subtypes in the control of physiological and behavioral responses
1994
Engineered Alkane‐Hydroxylating Cytochrome P450BM3 Exhibiting Nativelike Catalytic Properties
2007 StandoutNobel
Antipsychotic Drugs and Dopamine-Stimulated Adenylate Cyclase Prepared from Corpus Striatum of Rat Brain
1974
Aggression, suicide, and serotonin: relationships to CSF amine metabolites
1982
Computing with Neural Circuits: A Model
1986 StandoutScienceNobel
Cell loss in the locus coeruleus in senile dementia of Alzheimer type
1981
Neurogenetic Adaptive Mechanisms in Alcoholism
1987 StandoutScience
Rapid elevation of biogenic amine metabolites in human CSF following probenecid
1970 StandoutNobel
Anti-schizophrenic drugs—Membrane receptor sites of action
1977
TRYPTOPHAN IN THE TREATMENT OF DEPRESSION
1967
Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques
1977 Standout
Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
2002 StandoutNobel
Potentiation of a monoamine oxidase inhibitor by tryptophan
1969
Potentiation by α‐Methyltyrosine of the Suppression of Food‐Reinforced Lever‐Pressing Behaviour Induced by Antipsychotic Drugs
1977
The Steroid and Thyroid Hormone Receptor Superfamily
1988 StandoutScience
Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory turbercle of the rat
1975
Direct identification and characterisation of β-adrenergic receptors in rat brain
1975 StandoutNatureNobel
Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system
1973
Catalytic iron-carbene intermediate revealed in a cytochrome c carbene transferase
2018 StandoutNobel
5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid
1970 Nature
Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia
1980
Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type
1981
Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior
1983
Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis
1985
Choline uptake in patients with Alzheimer pre-senile dementia
1981
Development of antidepressant drugs. Fluoxetine (Prozac) and other selective serotonin uptake inhibitors.
1995
Metabolic fate of L-[14C] DOPA in cerebrospinal fluid and blood plasma of humans
1967
Are central pattern generators understandable?
1980
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
Reduced corticol choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide
1980
Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type
1980
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
2003 StandoutScience
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Spermidine in health and disease
2018 StandoutScience
Catecholamines and Neurologic Diseases
1975
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
1988 Standout
Monoamine Metabolism in Human Brain
1977
Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine
2010
Steroid Hormone Receptors in Human Breast Cancer
1983
Biochemical changes in the cholinergic system of the ageing brain and in senile dementia
1980
Noradrenaline release by nerve stimulation of the spinal cord
1965 StandoutNobel
CSF 5HIAA: Effects of probenecid and parachlorophenylalanine
1968
Deficient transport mechanism for the removal of acid monoamine metabolites from cerebrospinal fluid
1969
Multiple receptors for dopamine
1979 StandoutNature
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramine
1969 StandoutNobel
Effect of probenecid on the level of homovanillic acid in the corpus striatum
1966
Identification of Mechanism-Based Inactivation in P450-Catalyzed Cyclopropanation Facilitates Engineering of Improved Enzymes
2016 StandoutNobel
Biochemistry of Alzheimer's Dementia
1982
Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugs
1972
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
1970 Standout
Does dopamine play a role in schizophrenia?
1977 StandoutNobel
Plasticity of Hippocampal Circuitry in Alzheimer's Disease
1985 Science
Reduced concentrations of arginine vasopressin and MHPG in lumbar CSF of patients with Korsakoff's psychosis
1986
The Biochemistry of Affective Disorders
1967 Standout
THE EFFECT OF HYPOXIA ON MONOAMINE SYNTHESIS, LEVELS AND METABOLISM IN RAT BRAIN
1973 StandoutNobel
POTENTIATION OF ANTIDEPRESSANT ACTION OF CLOMIPRAMINE BY TRYPTOPHAN
1975 StandoutNobel
Brain Tryptophan Hydroxylation: Dependence on Arterial Oxygen Tension
1973 StandoutScienceNobel
The Cholinergic Hypothesis of Geriatric Memory Dysfunction
1982 StandoutScience
Computation Sheds Insight into Iron Porphyrin Carbenes’ Electronic Structure, Formation, and N–H Insertion Reactivity
2016
Rapid metabolic evolution in human prefrontal cortex
2011 StandoutNobel
Short-term memory in the rhesus monkey: Effects of dopamine blockade via acute haloperidol administration
1978
Pre-Bötzinger Complex: a Brainstem Region that May Generate Respiratory Rhythm in Mammals
1991 StandoutScience
On the interaction between pimozide and α-methyltyrosine
1973
Age-related behavioral and neurobiological changes: A review with an emphasis on memory
1981
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
1976 StandoutScience
Senile dementia of the Alzheimer type
1983
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
2007 StandoutScience
Alzheimer's Disease: Cell-Specific Pathology Isolates the Hippocampal Formation
1984 StandoutScience
The Dopamine Hypothesis of Schizophrenia: A Review*
1976
Potentiation by Metyrosine of Thioridazine Effects in Chronic Schizophrenics
1976
Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.
1978 StandoutNobel
Interaction of benzodiazepines with neuroleptics at central dopamine neurons
1976
ACCELERATED AGEING OR SELECTIVE NEURONAL LOSS AS AN IMPORTANT CAUSE OF DEMENTIA?
1979
Alternate Heme Ligation Steers Activity and Selectivity in Engineered Cytochrome P450-Catalyzed Carbene-Transfer Reactions
2018 StandoutNobel
Neurotransmitter metabolites, enzymes and receptors in experimental scrapie
1985
Effect of drugs used in psychoses on cerebral dopamine metabolism
1970
Opioid and Nonopioid Mechanisms of Stress Analgesia
1980 StandoutScience
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
2004 StandoutScience
Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant Neurotoxin
1987 StandoutScience
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Interacting neurotransmitter systems. A non-experimental approach to the 5hiaa-hva correlation in human CSF
1986
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
1983 StandoutScience
Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients
1969
Selective antagonists of benzodiazepines
1981 StandoutNature
Structure and Chemistry of Cytochrome P450
2005 Standout

Works of B. E. Roos being referenced

O2-binding to heme: electronic structure and spectrum of oxyheme, studied by multiconfigurational methods
2004
Post-mortem distribution of dopamine and homo-vanillic acid in human brain, variations related to age, and a review of the literature
1979
DETERMINATION OF 5‐HYDROXYTRYPTAMINE, 5‐HYDROXYINDOLEACETIC ACID AND HOMOVANILLIC ACID IN BRAIN TISSUE FROM AN AUTOPSY MATERIAL
1974
Correlation of steroid hormone receptor levels with histological grading in human breast cancer
1980
Late Effects on Rabbit Brain Morphology and Monoamine Metabolites Produced by60Co-Irradiation
1976
ACID MONOAMINE METABOLITES OF CEREBROSPINAL FLUID IN MENTAL DEPRESSION AND MANIA
1966
Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex
1971
The prevalence of insomnia: the importance of operationally defined criteria.
1988
The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
1993
Reciprocal Effects on α‐ and γ‐Motoneurones of Drugs Influencing Monoaminergic and Gholinergic Transmission
1966
Serum levels of thioridazine in psychiatric patients and healthy volunteers
1973
STUDIES OF THE MONOAMINE METABOLISM IN THE CENTRAL NERVOUS SYSTEM IN JAKOB-CREUTZFELDT DISEASE
1971
Fluorimetric Determination of Homovanillic Acid in Tissues, Using Anion Exchange Separation and Mixed Solvent Elution.
1971
THE EFFECT OF ENZYME INHIBITORS ON HISTAMINE CATABOLISM IN MAN
1960
On the occurrence of homovanillic acid and 3-methoxy-4-hydroxymandelic acid in human cerebrospinal fluid
1963
Effects of certain tranquillisers on the level of homovanillic acid in the corpus striatum
1965
Potentiation of phenothiazines by?-methyltyrosine in treatment of chronic schizophrenia
1972 StandoutNobel
A model of the central and reflex inhibition of inspiration in the cat
1975
Further studies on the mechanism of antipsychotic action: Potentiation by ?-methyltyrosine of thioridazine effects in chronic schizophrenics
1973 StandoutNobel
Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type
1979
Cerebrospinal Fluid pH and Monoamine and Glucolytic Metabolites in Alzheimer's Disease
1974
DETERMINATION OF MONOAMINE AND MONOAMINE METABOLITES IN THE HUMAN BRAIN: POST MORTEM STUDIES IN A GROUP OF SUICIDES AND IN A CONTROL GROUP
1976
The Investigation of Homovanillic Acid in the Human Brain and its Correlation to Senile Dementia
1969
Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's Disease
1968 Nature
HOMOVANILLIC ACID AND 5‐HYDROXYINDOLEACETIC ACID IN THE CEREBROSPINAL FLUID OF PATIENTS WITH SENILE DEMENTIA, PRESENILE DEMENTIA AND PARKINSONISM
1969
5-hydroxyindoleacetic acid (and homovanillic acid) levels in the cerebrospinal fluid after probenecid application in patiens with manic-depressive psychosis
1969
Rankless by CCL
2026